Show
Sort by
-
- Journal Article
- A1
- open access
Whole slide imaging-based prediction of TP53 mutations identifies an aggressive disease phenotype in prostate cancer
-
- Journal Article
- A1
- open access
Quantification of neoantigen-mediated immunoediting in cancer evolution : letter
-
Immunotherapeutic targeting and PET imaging of DLL3 in small-cell neuroendocrine prostate cancer
-
Heterogeneity of CAFfeinated tumors : sweet targeting perspectives
-
- Journal Article
- A1
- open access
Efficacy of CD40 agonists is mediated by distinct cDC subsets and subverted by suppressive macrophages
-
Adherence to and patient satisfaction with the combination therapy of exemestane and everolimus in postmenopausal women with HR+ HER2- advanced breast cancer : results from the IPSOC-mamma study
-
Loss-of-function mutations in TRAF7 and KLF4 cooperatively activate RAS-like GTPase signaling and promote meningioma development
-
The EMT transcription factor ZEB2 promotes proliferation of primary and metastatic melanoma while suppressing an invasive, mesenchymal-like phenotype
-
Fatty acid binding protein 7 regulates beige fat-like differentiation of breast cancer cells and thermogenesis
-
Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness
-
Splenic hematopoietic and stromal cells in cancer progression
-
A phase Ib study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in combination with atezolizumab in patients with locally advanced or metastatic solid tumors
-
Global alteration of CTCF binding in the cancer genome
-
Associations of aspirin, non-aspirin NSAIDs, statins, and metformin with risk of biliary tract cancer : a Swedish population-based cohort study
-
PHF6loss drives IL7R oncogene addiction in TLX1 driven T-ALL